Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Mobilio

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell functionAgata M Kieliszek, Erika Apel, Suky Zheng, et al.
Science Translational Medicine|May 13, 2026
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell targetWilliam T Maich, Muhammad Vaseem Shaikh, Anish Puri, et al.
Science Translational Medicine|July 2, 2025
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasisShawn C Chafe, Kui Zhai, Nikoo Aghaei, et al.
Nature Medicine|August 2, 2024
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cellsChirayu R Chokshi, Muhammad Vaseem Shaikh, Benjamin Brakel, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell functionAgata M Kieliszek, Erika Apel, Suky Zheng, et al.
Science Translational Medicine|May 13, 2026
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell targetWilliam T Maich, Muhammad Vaseem Shaikh, Anish Puri, et al.
Science Translational Medicine|July 2, 2025
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasisShawn C Chafe, Kui Zhai, Nikoo Aghaei, et al.
Nature Medicine|August 2, 2024
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cellsChirayu R Chokshi, Muhammad Vaseem Shaikh, Benjamin Brakel, et al.
Pageof 2